Antibiotic Therapy and Treatment Failure in Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease

被引:155
作者
Rothberg, Michael B. [1 ,2 ,4 ]
Pekow, Penelope S. [2 ,5 ]
Lahti, Maureen [5 ]
Brody, Oren [1 ,4 ]
Skiest, Daniel J. [3 ]
Lindenauer, Peter K. [2 ,4 ]
机构
[1] Baystate Med Ctr, Div Gen Med & Geriatr, Springfield, MA 01199 USA
[2] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA
[3] Baystate Med Ctr, Div Infect Dis, Springfield, MA 01199 USA
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
[5] Univ Massachusetts, Sch Publ Hlth, Amherst, MA 01003 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2010年 / 303卷 / 20期
关键词
MANAGEMENT; DIAGNOSIS; COPD;
D O I
10.1001/jama.2010.672
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Guidelines recommend antibiotic therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD), but the evidence is based on small, heterogeneous trials, few of which include hospitalized patients. Objective To compare the outcomes of patients treated with antibiotics in the first 2 hospital days with those treated later or not at all. Design, Setting, and Patients Retrospective cohort of patients aged 40 years or older who were hospitalized from January 1, 2006, through December 31, 2007, for acute exacerbations of COPD at 413 acute care facilities throughout the United States. Main Outcome Measures A composite measure of treatment failure, defined as the initiation of mechanical ventilation after the second hospital day, inpatient mortality, or readmission for acute exacerbations of COPD within 30 days of discharge; length of stay, and hospital costs. Results Of 84 621 patients, 79% received at least 2 consecutive days of antibiotic treatment. Treated patients were less likely than nontreated patients to receive mechanical ventilation after the second hospital day (1.07%; 95% confidence interval [CI], 1.06%-1.08% vs 1.80%; 95% CI, 1.78%-1.82%), had lower rates of inpatient mortality (1.04%; 95% CI, 1.03%-1.05% vs 1.59%; 95% CI, 1.57%-1.61%), and had lower rates of readmission for acute exacerbations of COPD (7.91%; 95% CI, 7.89%-7.94% vs 8.79%; 95% CI, 8.74%-8.83%). Patients treated with antibiotic agents had a higher rate of readmissions for Clostridium difficile (0.19%; 95% CI, 0.187%-0.193%) than those who were not treated (0.09%; 95% CI, 0.086%-0.094%). After multivariable adjustment, including the propensity for antibiotic treatment, the risk of treatment failure was lower in antibiotic-treated patients (odds ratio, 0.87; 95% CI, 0.82-0.92). A grouped treatment approach and hierarchical modeling to account for potential confounding of hospital effects yielded similar results. Analysis stratified by risk of treatment failure found similar magnitudes of benefit across all subgroups. Conclusion Early antibiotic administration was associated with improved outcomes among patients hospitalized for acute exacerbations of COPD regardless of the risk of treatment failure. JAMA. 2010;303(20):2035-2042 www.jama.com
引用
收藏
页码:2035 / 2042
页数:8
相关论文
共 25 条
[1]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[2]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[3]   Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease [J].
Daniels, Johannes M. A. ;
Snijders, Dominic ;
de Graaff, Casper S. ;
Vlaspolder, Fer ;
Jansen, Henk M. ;
Boersma, Wim G. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (02) :150-157
[4]   Comorbidity measures for use with administrative data [J].
Elixhauser, A ;
Steiner, C ;
Harris, DR ;
Coffey, RN .
MEDICAL CARE, 1998, 36 (01) :8-27
[5]   Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study [J].
Groenewegen, KH ;
Wouters, EFM .
RESPIRATORY MEDICINE, 2003, 97 (07) :770-777
[6]   Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates [J].
Johnston, SC ;
Henneman, T ;
McCulloch, CE ;
van der Laan, M .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (08) :753-760
[7]   Infectious etiologies in acute exacerbation of COPD [J].
Lieberman, D ;
Lieberman, D ;
Ben-Yaakov, M ;
Lazarovich, Z ;
Hoffman, S ;
Ohana, B ;
Friedman, MG ;
Dvoskin, B ;
Leinonen, M ;
Boldur, I .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (03) :95-102
[8]   Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease [J].
Lindenauer, Peter K. ;
Pekow, Penelope ;
Gao, Shan ;
Crawford, Allison S. ;
Gutierrez, Benjamin ;
Benjamin, Evan M. .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) :894-903
[9]  
Moody A, 2004, THORAX, V59, P1
[10]  
*NAT HEART LUNG BL, TAK 1 STEP BREATH BE